0 CHECKOUT

Hungary Pharmaceuticals and Healthcare Report Q1 2016

  • ID: 3495122
  • November 2015
  • Region: Hungary
  • 81 pages
  • Business Monitor International
1 of 4

Hungary's pharmaceutical market represents a moderate but reliable commercial prospect within Central and Eastern Europe. The government plays a key role in the provision of medical services as demonstrated by its recent ban on parallel exports of medicines and the decentralisation of primary care.

We nevertheless expect the private sector to become more involved over the medium term.

Headline Expenditure Projections
- Pharmaceuticals: HUF648.10bn (USD2.79bn) in 2014 to HUF660.80bn (USD2.36bn) in 2015; +2.0%
in local currency terms and -15.3% in US dollar terms.

- Healthcare: HUF2.38trn (USD10.22bn) in 2014 to HUF2.42trn (USD8.65bn) in 2015; +1.9% in local currency terms and -15.3% in US dollar terms.

Note: Product cover images may vary from those shown
2 of 4

Table: Headline Pharmaceuticals & Healthcare Forecasts (Hungary 2013-2019)

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Hungary 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2011-2019)

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Hungary 2011-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Hungary 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Hungary 2011-2019)

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Hungary 2011-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Hungary 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Hungary 2013-2019)

Industry Risk Reward Index

Central And Eastern Europe Risk/Reward Index - Q1 2016

Hungary Risk/Reward Index

Rewards

Risks

Regulatory Review

Intellectual Property Issues

Pricing Regime
Table: OEP Reimbursement Changes, September 2014

Reimbursement Regime

Market Overview

Healthcare System
Table: Healthcare Resources (Hungary 2009-2014)
Table: Healthcare Personnel (Hungary 2009-2014)
Table: Healthcare Activity (Hungary 2009-2014)

Healthcare Funding

Research & Development

Clinical Trials

Epidemiology

Competitive Landscape

Research Based Industry
Table: Multinational Market Activity

Generic Drugmakers

Pharmaceutical Distribution

Pharmaceutical Retail Sector

Company Profile

Egis Pharmaceuticals (Servier)

Gedeon Richter

Demographic Forecast
Table: Population Headline Indicators (Hungary 1990-2025)
Table: Key Population Ratios (Hungary 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Hungary 1990-2025)
Table: Population By Age Group (Hungary 1990-2025)
Table: Population By Age Group % (Hungary 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

Egis Pharmaceuticals (Servier)
Gedeon Richter

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Pfizer Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S